MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells

doi:10.3748/wjg.v16.i42.5334

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 42

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4176)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series.

Item

Count

PDF

420

HTML

3419

Figures (1-7)

337

Sum=4176

Nov 14, 2010 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 14, 2010; 16(42): 5334-5341
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334

Full Size Figure Download Figure

Figure 5 MK615 does not decrease receptor of advanced glycation end-product mRNA. The concentration of receptor of advanced glycation end-product mRNA did not differ between MK615-treated HuH7 and HepG2 cells.

Citation: Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T, Adachi M, Takino JI, Takeuchi M, Kubota K. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World J Gastroenterol 2010; 16(42): 5334-5341
URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5334.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5334